8-K: ANVI Global Holdings Approves 1-for-20 Reverse Stock Split

ANVI Global Holdings, Inc. has approved a 1-for-20 reverse stock split to address a minimum bid price deficiency and avoid potential delisting from the OTCQB Venture Market.

Summary

• ANVI Global Holdings, Inc. (the Company) has approved a 1-for-20 reverse stock split.
• This action was approved by the holder of approximately 60.03% of the Company's voting stock via a Written Consent in lieu of a special meeting.
• The reverse stock split is intended to address a deficiency notice received from OTC Markets Group Inc. on June 6, 2026, regarding the Company's minimum closing bid price falling below $0.01 for 30 consecutive days.
• The Company was initially given a compliance cure deadline of October 5, 2026.
• A previously planned corporate transaction to inject an exploration mining asset was delayed due to unforeseen geopolitical tensions and the inability to finalize technical assessments within the required timeframe.
• The reverse stock split is subject to SEC Schedule 14C clearance and FINRA approval.
• The market effective date will be at least twenty (20) calendar days after a Definitive Information Statement on Schedule 14C is mailed to stockholders.
• The Company is also requesting a 60-day listing cure period extension from OTC Markets Group.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development, as the reverse stock split is a measure to avoid delisting due to a low stock price, indicating underlying business challenges.

Positives

• The company is taking proactive steps to maintain its listing on the OTCQB Venture Market.
• The majority stockholder has approved the necessary action, streamlining the process.
• The company is seeking an extension for the listing cure period, providing additional time.

Negatives

• The company's stock price has fallen below the minimum bid price requirement for 30 consecutive days, indicating significant market concern.
• A planned asset injection transaction, intended to address compliance issues, has been significantly delayed.
• The reverse stock split is a measure to avoid delisting, suggesting underlying financial or operational difficulties.
• The company faces potential delisting to the OTC Pink Open Market if compliance is not achieved.

Risks

• Failure to obtain SEC Schedule 14C clearance or FINRA approval for the reverse stock split.
• Inability to meet the continued eligibility criteria of the OTCQB Venture Market even after the reverse stock split.
• Further delays in the exploration mining asset transaction due to ongoing geopolitical tensions or technical challenges.
• Potential negative market reaction to the reverse stock split, which is often viewed as a sign of distress.

Future Outlook

The immediate future outlook is focused on obtaining SEC and FINRA approvals for the reverse stock split and securing an extension for the OTC listing compliance period. The success of these steps is critical to avoid delisting. The long-term outlook remains uncertain, dependent on the successful integration of the exploration mining asset and overall market performance.

Management Comments

• Management pivoted to a structural reverse stock split adjustment to definitively address the bid price requirement and avoid a listing downgrade to the OTC Pink Open Market.
• The definitive exploration and technical phase of the mine could not be completed within that anticipated timeframe.
• This delay was severely compounded by unexpected regional geopolitical tensions, which temporarily halted field operations and international technical clearings.

Industry Context

StockSavvy.ai notes that reverse stock splits are often employed by companies facing delisting threats due to low stock prices. While a necessary measure to maintain exchange listing, it does not address the underlying business issues that led to the low valuation. Competitors in similar market segments often face similar pressures, but successful companies typically focus on fundamental growth rather than purely structural adjustments.

Stakeholder Impact

• Shareholders: The reverse stock split will reduce the number of outstanding shares, potentially increasing the per-share price but not necessarily the overall market capitalization. It may also dilute the voting power of smaller shareholders if not all shares are consolidated proportionally.
• Creditors: No direct immediate impact mentioned, but continued listing and operational stability are indirectly beneficial.
• Employees: No direct impact mentioned, but maintaining listing is crucial for company stability and morale.
• OTC Markets Group: The company is actively engaging with OTC Markets Group to comply with listing rules.

Next Steps

• File and distribute a Schedule 14C Information Statement to non-consenting stockholders.
• Await SEC Schedule 14C clearance.
• Obtain FINRA approval for the reverse stock split.
• Await the expiration of at least twenty (20) calendar days after mailing the Schedule 14C.
• Submit an update notification to the FINRA Corporate Actions Gateway.
• Transmit a formal request to OTC Markets Group Compliance for a 60-day listing cure period extension.

Key Dates

Recommendation

The filing indicates a company in distress, taking measures to avoid delisting rather than demonstrating fundamental business improvement. While the reverse stock split and extension request are attempts to stabilize the situation, the underlying issues causing the low bid price and the delays in asset integration remain significant concerns. A 'hold' recommendation reflects the uncertainty and the need for further developments to demonstrate a sustainable recovery.

Keywords

Reverse Stock Split, OTC Listing, Bid Price, Compliance, Delisting, Stockholder Consent, Information Statement, Mining Asset